Six-question risk score can identify HIV-positive gay men needing testing for acute hepatitis C

nam/aidsmap, 5th June 2017

Six questions can identify HIV-positive gay men who are at elevated risk of having acute (recent) hepatitis C infection and who would benefit from further testing, according to a paper published in Eurosurveillance last week. The risk score was based on data from a Dutch cohort and has been validated with separate datasets from Belgium, the Netherlands and England.

The six questions in the risk score concern self-reported behaviours:

  • Condomless receptive anal intercourse in the past six months (score 1.1)
  • Sharing of sex toys in the past six months (score 1.2)
  • Fisting without gloves in the past six months (score 0.9)
  • Injecting drug use in the past 12 months (score 1.4)
  • Sharing of straws to snort drugs in the past 12 months (score 1.0)
  • An ulcerative sexually transmitted infection in the past 12 months (score 1.4)

Read more here 

London data shows that hepatitis C is passed on during [sexual activity]

aidsmap/nam, 10 April 2017

Around one in five HIV-positive gay men who recently acquired hepatitis C report anal sex without a condom as the only behaviour that could explain their infection. At the same time, a third of people acquiring hepatitis C were gay men who did not have HIV, clinicians from the Mortimer Market Centre in London told the British HIV Association conference in Liverpool last week.

The data suggest that prevention messages around sexually transmitted hepatitis C need to change.

Read more here 

HIV vaccine research: Adelaide team achieves ‘glimpse in right direction’

ABC News, 21.11.16

Progress toward vaccinating people against HIV infection has been announced by Adelaide researchers.

A team from the University of Adelaide and the Basil Hetzel Institute at Adelaide’s Queen Elizabeth Hospital used a combined vaccination approach, researcher Dr Branka Grubor-Bauk explained.

  • Read more here
  • Access article in Nature Scientific Reports (open access) here

Why do certain hormonal contraceptives increase the risk of HIV?

American Society for Microbiology, 1st September 2015

In recent years, evidence has been building that injectable contraceptive depot medroxyprogesterone acetate (Depo-Provera or DMPA) is associated with an increased risk of HIV infection. Now a study published in the September 1st issue of mBio, an online open-access journal of the American Society for Microbiology, provides a biological explanation for the phenomenon.

Read more here